1. Home
  2. SPTN vs ANAB Comparison

SPTN vs ANAB Comparison

Compare SPTN & ANAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPTN
  • ANAB
  • Stock Information
  • Founded
  • SPTN 1917
  • ANAB 2005
  • Country
  • SPTN United States
  • ANAB United States
  • Employees
  • SPTN N/A
  • ANAB N/A
  • Industry
  • SPTN Food Distributors
  • ANAB Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPTN Consumer Discretionary
  • ANAB Health Care
  • Exchange
  • SPTN Nasdaq
  • ANAB Nasdaq
  • Market Cap
  • SPTN 596.4M
  • ANAB 621.1M
  • IPO Year
  • SPTN N/A
  • ANAB 2017
  • Fundamental
  • Price
  • SPTN $26.82
  • ANAB $20.33
  • Analyst Decision
  • SPTN Hold
  • ANAB Buy
  • Analyst Count
  • SPTN 1
  • ANAB 10
  • Target Price
  • SPTN $26.90
  • ANAB $48.00
  • AVG Volume (30 Days)
  • SPTN 728.9K
  • ANAB 444.8K
  • Earning Date
  • SPTN 08-14-2025
  • ANAB 08-06-2025
  • Dividend Yield
  • SPTN 3.28%
  • ANAB N/A
  • EPS Growth
  • SPTN N/A
  • ANAB N/A
  • EPS
  • SPTN N/A
  • ANAB N/A
  • Revenue
  • SPTN $9,693,074,000.00
  • ANAB $123,164,000.00
  • Revenue This Year
  • SPTN $6.07
  • ANAB $11.22
  • Revenue Next Year
  • SPTN N/A
  • ANAB $8.35
  • P/E Ratio
  • SPTN N/A
  • ANAB N/A
  • Revenue Growth
  • SPTN 1.54
  • ANAB 304.17
  • 52 Week Low
  • SPTN $17.30
  • ANAB $12.21
  • 52 Week High
  • SPTN $26.86
  • ANAB $40.70
  • Technical
  • Relative Strength Index (RSI)
  • SPTN 77.70
  • ANAB 38.61
  • Support Level
  • SPTN $26.54
  • ANAB $19.68
  • Resistance Level
  • SPTN $26.70
  • ANAB $20.81
  • Average True Range (ATR)
  • SPTN 0.09
  • ANAB 0.82
  • MACD
  • SPTN -0.05
  • ANAB 0.10
  • Stochastic Oscillator
  • SPTN 91.43
  • ANAB 33.33

About SPTN SpartanNash Company

SpartanNash Co is a food solutions company that delivers the ingredients. Its principal business activities include, distributing grocery products to a diverse group of independent and chain retailers, its corporate-owned retail stores, and U.S. military commissaries and exchanges; as well as operating a fresh produce distribution network and the Our Family private label brand. The company operates in two segments: Retail and Wholesale. Majority of the revenue is earned from its Wholesale segment which uses a multi-channel sales approach to distribute national brand and private brand products to independent retailers, national accounts, food service distributors, e-commerce providers, and the Company's corporate owned retail stores.

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

Share on Social Networks: